Mutant KRAS promotes malignant pleural effusion formation

Malignant pleural effusion (MPE) is a lethal condition associated with various cancers. Here, the authors show that cancer cells with KRAS mutations promote MPE by recruiting myeloid cells via CCL2 signalling and that pharmaceutical targeting of KRAS results in reduced MPE incidence and volume in mouse models.